These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2327273)

  • 1. The dexamethasone suppression test and completed suicide.
    Norman WH; Brown WA; Miller IW; Keitner GI; Overholser JC
    Acta Psychiatr Scand; 1990 Feb; 81(2):120-5. PubMed ID: 2327273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide.
    Jokinen J; Nordström AL; Nordström P
    J Affect Disord; 2008 Feb; 106(1-2):145-52. PubMed ID: 17662471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry and suicidal behavior in depressed patients.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis J; Maas JW; Landis H
    Biol Psychiatry; 1986 Jul; 21(8-9):756-67. PubMed ID: 3730460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DST non-suppression predicts suicide after attempted suicide.
    Jokinen J; Carlborg A; Mårtensson B; Forslund K; Nordström AL; Nordström P
    Psychiatry Res; 2007 Apr; 150(3):297-303. PubMed ID: 17316825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test and suicide prediction.
    Coryell W; Schlesser M
    Am J Psychiatry; 2001 May; 158(5):748-53. PubMed ID: 11329397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):117-20. PubMed ID: 19054569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicide and the dexamethasone suppression test in unipolar depression.
    Coryell W; Schlesser MA
    Am J Psychiatry; 1981 Aug; 138(8):1120-1. PubMed ID: 7258395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
    Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in children and adolescents: a review and a controlled study.
    Dahl RE; Kaufman J; Ryan ND; Perel J; al-Shabbout M; Birmaher B; Nelson B; Puig-Antich J
    Biol Psychiatry; 1992 Jul; 32(2):109-26. PubMed ID: 1420629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior.
    Banki CM; Arató M
    Psychiatry Res; 1983 Dec; 10(4):253-61. PubMed ID: 6199807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of the dexamethasone suppression test as a marker for endogenous depression.
    Zimmerman M; Coryell W; Pfohl B
    Arch Gen Psychiatry; 1986 Apr; 43(4):347-55. PubMed ID: 3954557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.
    Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å
    Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test and DSM-III-R diagnoses in suicide attempters.
    Westrin A; Frii K; Träskman-Bendz L
    Eur Psychiatry; 2003 Nov; 18(7):350-5. PubMed ID: 14643563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters.
    Westrin A; Niméus A
    Eur Psychiatry; 2003 Jun; 18(4):166-71. PubMed ID: 12814849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
    Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
    J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.